Rephine is our GMP and regulatory
partner for this plant, as well as for future
businesses in initial phases
Client Testimonial
About this Case Study
For a young biotech company with just six employees, launching a new automated manufacturing plant was an exciting step forward. It was also a major regulatory challenge. With limited internal GMP experience, the company needed to achieve EU GMP compliance without slowing daily operations or delaying authorisation.
Rephine supported the client from early facility design through to qualification and validation, designing a practical Quality Management System suited to a small, highly automated organisation. The focus was on embedding GMP requirements into everyday operations in a way that felt manageable and sustainable for a lean team.
By combining technical expertise with close collaboration and knowledge transfer, Rephine helped the client move confidently from start up to authorised manufacturer.
Key outcomes included:
- EU GMP authorisation for the new manufacturing facility
- A right sized QMS aligned to the realities of a small organisation
- Successful audit outcomes and improved regulatory confidence
- Increased business credibility and growth opportunities
- GMP knowledge embedded across operational teams
✅ Download the full case study to discover:
- How small biotech companies can achieve GMP compliance with limited resources
- How early GMP input supports smoother facility qualification and validation
- How practical consultancy accelerates readiness without over complexity
Result: A compliant, authorised manufacturing operation supported by a scalable QMS and a trusted GMP partner.
Download the Case Study
View other our other resources and company news
Case Study From Cosmetics to OTC: Full FDA GMP Compliance Achieved in 12 Months
A global cosmetics manufacturer wanted to enter the OTC pharmaceutical market but had zero GMP experience. In 12 months, their Spanish production site achieved full ...
Read More
Article GDP Transport Validation: A Practical Guide for Pharmaceutical Companies
Transport validation is a regulatory requirement under EU GMP Annex 15, yet many pharmaceutical companies still struggle with route selection and risk assessment. This guide ...
Read More
Article Veterinary GMP in Europe: New Dedicated Framework & VICH GL60 Guide
The EU veterinary sector enters a new era on 16 July 2026. Dedicated GMP regulations replace EudraLex Volume 4 for veterinary products. Learn what changes ...
Read More
Article MDR & IVDR Compliance: A Strategic Approach for MedTech
Regulatory compliance under MDR and IVDR has moved beyond documentation to become a strategic discipline that shapes every stage of a medical device's lifecycle. This ...
Read More
Medical Device MDR & IVDR Compliance as a Business Outcome
Rephine's 2026 White Paper on MDR & IVDR compliance: strategic guidance for MedTech companies to reduce regulatory risk, avoid delays, and reach the EU market ...
Read More
Case Study Full GMP Internal Audit Program Executed On Time
A pharmaceutical manufacturer needed to complete their annual EU GMP internal audit cycle across 11 departments, without the internal capacity to do it. See how ...
Read More
QMS From local to global: scaling your QMS for UK–EU operations
Learn how UK life sciences companies can scale their quality management system into EU markets without losing compliance, visibility, or operational control.
Read More
QMS Scale Your Quality System from UK to EU Without Losing Control
Learn how UK life sciences companies can scale their quality management system into EU markets without losing compliance, visibility, or operational control.
Read More
Article Pharmaceutical Equipment Qualification & Control System Validation
Qualifying process equipment and control systems is fundamental to GMP compliance. This guide breaks down how to define user requirements, apply risk-based testing, and maintain ...
Read More
